IAN HORKHEIMER, MD
Specialist · LITTLE SILVER, NJ
Individual Active NPI 1316924772
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 845 | 221,200 | $19,027,178 | $5,584,604 | $4,445,614 |
| 2023 | 746 | 181,713 | $15,051,317 | $4,934,344 | $3,924,227 |
| 2022 | 743 | 212,518 | $9,934,050 | $4,743,013 | $3,785,884 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 9,500 | $56 | $45 |
| J0185 | Injection, aprepitant, 1 mg | 9,360 | $2 | $1 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 8,640 | $50 | $39 |
| J9267 | Injection, paclitaxel, 1 mg | 6,955 | $0 | $0 |
| J1437 | Injection, ferric derisomaltose, 10 mg | 4,400 | $20 | $16 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 3,870 | $0 | $0 |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 3,792 | $7 | $6 |
| J0897 | Injection, denosumab, 1 mg | 2,460 | $26 | $21 |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 2,376 | $26 | $21 |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,995 | $8 | $8 |
| 36415 | Insertion of needle into vein for collection of blood sample | 1,646 | $9 | $9 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,590 | $31 | $25 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Specialist | 174400000X | ✓ | 25MA08068100 | NJ |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Specialist providers in New Jersey
- NPI 1285629550
- NPI 1699720417
- NPI 1407441033
- NPI 1477683340
- NPI 1295720563
- NPI 1053757914
- NPI 1316108517
- NPI 1104817576
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.